Monoamine transporter and receptor

Monoamine transporters and receptors constitute a broad class of proteins that regulate the signaling of biogenic amines, including serotonin, dopamine, and norepinephrine, within the central and peripheral nervous systems [1]. Transporters, such as the serotonin transporter (SERT), dopamine transporter (DAT), and norepinephrine transporter (NET), are responsible for the reuptake of neurotransmitters from the synaptic cleft, thereby terminating the signal and recycling the molecules [2]. Receptors for these neurotransmitters, which are predominantly G protein-coupled receptors (GPCRs) but also include ligand-gated ion channels like the 5-HT3 receptor, mediate the physiological response to these chemicals [3]. This complex system is essential for modulating a wide array of biological processes, including mood, arousal, cognition, reward, and autonomic functions [4]. Dysfunction within the monoaminergic system is a hallmark of numerous psychiatric and neurological conditions, such as major depressive disorder, anxiety, schizophrenia, attention deficit hyperactivity disorder (ADHD), and Parkinson's disease [5]. Because of their central role in neurotransmission, these proteins are primary targets for a significant portion of modern pharmacotherapy [6]. Drugs interacting with these targets include selective serotonin reuptake inhibitors (SSRIs) for depression, stimulants for ADHD, and antipsychotics that block dopamine receptors [1, 6]. Therapeutic intervention often aims to restore chemical balance by either inhibiting reuptake or directly modulating receptor activity, though such treatments require careful management due to potential side effects like serotonin syndrome or extrapyramidal symptoms [2, 5].

Other names

Monoaminergic systemBiogenic amine transporters and receptorsMonoamine signaling complex

Reuptake inhibition, receptor agonism, and receptor antagonism [1, 6]